Company: LCTX
Filing Date: 2025-04-29
Form Type: DEF 14A
Source: 0000950170-25-060090
Chunk: 18

Company: Lineage Cell Therapeutics, Inc.
Filing Date: 2025-04-29
Form: DEF 14A
Chunk 18
---
 Deborah Andrews       |     | Chair  |     | Member       |     |             |     |           |
| Don M. Bailey         |     | Member |     |              |     | Member      |     |           |
| Neal C. Bradsher, CFA |     |        |     |              |     | Chair       |     | Member    |
| Brian M. Culley       |     |        |     |              |     |             |     | Chair     |
| Anula Jayasuriya      |     |        |     |              |     | Member      |     |           |
| Michael H. Mulroy     |     | Member |     | Member       |     |             |     | Member    |
| Angus C. Russell      |     | Member |     | Chair        |     |             |     |           |

Audit Committee Our Audit Committee held 8 meetings during 2024. The purpose of our Audit Committee is to recommend the engagement of our independent registered public accounting firm, to review their performance and the plan, scope, and results of the audit, and to review and approve the fees we pay to our independent registered public accounting firm. Our Audit Committee also will review our accounting and financial reporting procedures and controls, and all transactions between us and our executive officers, directors, and 5% Shareholders. Our Audit Committee also has oversight of risks related to information security (including cybersecurity) and regularly (i) reviews our information security policies, systems, and controls at its regularly scheduled meetings and as requested by our Audit Committee from time to time, (ii) assesses the potential impact of exposure to such risk on our business, financial results, operations and reputation, (iii) reviews steps management has taken to monitor and mitigate such exposures, and (iv) briefs our Board on information security matters. See Item 1C., Cybersecurity, of our Annual Report on Form 10-K for the fiscal year ended December 31, 2024 for additional information regarding cybersecurity risk management strategy and governance. Our Audit Committee has a written charter that requires the members of our Audit Committee to be directors who are independent in accordance with Section 803(A) and Section 803(B) of the NYSE American Company Guide and Section 10A-3 under the Exchange Act. A copy of the charter of our Audit Committee is posted on our website at https://investor.lineagecell.com/corporate-governance/highlights . Our Board has determined that each of Ms. Andrews